These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 2253682
21. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A, Auffredou MT, Gerard JP, Delfraissy JF, Galanaud P. J Immunol; 1987 Oct 01; 139(7):2344-8. PubMed ID: 3116080 [Abstract] [Full Text] [Related]
22. Spontaneous production of B cell growth factors by SLE lymphocytes. Pelton BK, Denman AM. Clin Exp Immunol; 1987 Jan 01; 67(1):159-66. PubMed ID: 3497742 [Abstract] [Full Text] [Related]
25. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y. Rheumatology (Oxford); 2007 Jul 01; 46(7):1083-6. PubMed ID: 17500077 [Abstract] [Full Text] [Related]
26. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q. Rheumatology (Oxford); 2005 Oct 01; 44(10):1245-54. PubMed ID: 15987711 [Abstract] [Full Text] [Related]
27. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N. Arthritis Res Ther; 2006 Oct 01; 8(3):R62. PubMed ID: 16563187 [Abstract] [Full Text] [Related]
28. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response. Karray S, Delfraissy JF, Merle-Beral H, Wallon C, Debre P, Galanaud P. J Immunol; 1988 Feb 01; 140(3):774-8. PubMed ID: 3257503 [Abstract] [Full Text] [Related]
29. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide. Hrycek A, Kusmierz D, Dybała T, Swiatkowska L. Autoimmunity; 2007 Feb 01; 40(1):23-30. PubMed ID: 17364494 [Abstract] [Full Text] [Related]
30. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. Suzuki N, Sakane T. J Clin Invest; 1989 Mar 01; 83(3):937-44. PubMed ID: 2646322 [Abstract] [Full Text] [Related]
31. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN. Arthritis Rheum; 2004 Feb 01; 50(2):629-39. PubMed ID: 14872508 [Abstract] [Full Text] [Related]
32. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M, Iwato K, Kuramoto A. J Immunol; 1985 Jan 01; 134(1):375-81. PubMed ID: 3871108 [Abstract] [Full Text] [Related]
33. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus]. Peng KJ, Xiao LS, Fei Y, Wang SR. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov 01; 22(6):769-71. PubMed ID: 17077019 [Abstract] [Full Text] [Related]
34. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression. Tanaka Y, Saito K, Suzuki H, Eto S, Yamashita U. J Immunol; 1989 Sep 01; 143(5):1584-90. PubMed ID: 2527267 [Abstract] [Full Text] [Related]
35. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. Nagafuchi H, Suzuki N, Mizushima Y, Sakane T. J Immunol; 1993 Dec 01; 151(11):6525-34. PubMed ID: 8245483 [Abstract] [Full Text] [Related]
36. Differential effects of interleukin 2 vs B cell growth factor on human B cells. Nakagawa T, Nakagawa N, Ambrus JL, Fauci AS. J Immunol; 1988 Jan 15; 140(2):465-9. PubMed ID: 2447179 [Abstract] [Full Text] [Related]
37. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. Saiki O, Saeki Y, Kishimoto S. J Clin Invest; 1985 Nov 15; 76(5):1865-70. PubMed ID: 3932473 [Abstract] [Full Text] [Related]
38. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O. Scand J Immunol; 2007 Nov 15; 66(5):584-90. PubMed ID: 17868260 [Abstract] [Full Text] [Related]
39. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus. Lu LY, Chu JJ, Lu PJ, Sung PK, Hsu CM, Tseng JC. J Microbiol Immunol Infect; 2008 Apr 15; 41(2):165-73. PubMed ID: 18473105 [Abstract] [Full Text] [Related]
40. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. Ambrus JL, Chesky L, Stephany D, McFarland P, Mostowski H, Fauci AS. J Immunol; 1990 Dec 15; 145(12):3949-55. PubMed ID: 2258603 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]